By Deena Beasley SAN DIEGO, June 23 (Reuters) – U.S. biotechnology industry trade group BIO worked with the Food and Drug Administration on plans announced on Monday to speed clinical trials and
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
BRIEF-Orsted CEO Says Key Focus Of Company's Capital Allocation Is Still On Offshore Wind In Europe
Aug 13 (Reuters) - Oersted A/S: * ORSTED CFO: WE CURRENTLY EXPECT STARTING POINT OF…
DeepSeek releases official V4 Pro model as it steps up expansion
BEIJING, Aug 13 (Reuters) - Chinese artificial intelligence startup DeepSeek on Thursday formally released its…
S&P 500, Nasdaq set for higher open as investors weigh weaker oil, PPI data
By Avinash P and Purvi Agarwal Aug 13 (Reuters) - The S&P 500 and the…
